Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats

被引:37
|
作者
Boesen, Erika I. [1 ]
Williams, Douglas L. [1 ]
Pollock, Jennifer S. [1 ]
Pollock, David M. [1 ]
机构
[1] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA
基金
美国国家卫生研究院;
关键词
hypertension; kidney; macrophage; mineralocorticoid; T-lymphocyte; IMMUNE CELL INFILTRATION; ANGIOTENSIN-II; SENSITIVE HYPERTENSION; BLOOD-PRESSURE; RENAL DAMAGE; MINERALOCORTICOID RECEPTORS; ARTERIAL-PRESSURE; OXIDATIVE STRESS; T-CELL; KIDNEY;
D O I
10.1111/j.1440-1681.2010.05428.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P>1. The interplay between the immune and renin-angiotensin systems is emerging as a crucial factor in the development and progression of hypertension. The aim of the present study was to determine the involvement of immune cells in the hypertension and renal injury produced by a non-angiotensin II-dependent form of hypertension, namely deoxycorticosterone acetate (DOCA)-salt-induced hypertension, in rats. 2. Male Sprague-Dawley rats underwent uninephrectomy and received either a sustained-release pellet of DOCA s.c. and 0.9% NaCl (saline) to drink for 21 days or a placebo pellet and water to drink for 21 days. Additional groups of DOCA-salt- and placebo-treated rats were treated concurrently with the immune suppressant mycophenolate mofetil (MMF; 30 mg/kg per day). Rats were placed in metabolic cages for 24 h urine collection prior to and at weekly intervals during the 21 day experimental period. 3. Mycophenolate mofetil significantly attenuated the development of hypertension in DOCA-salt rats compared with untreated DOCA-salt hypertensive rats (mean arterial pressure by telemetry on Day 18 146 +/- 7 vs 180 +/- 3 mmHg, respectively; P < 0.001), as well as proteinuria (87 +/- 27 vs 305 +/- 63 mg/day, respectively, on Day 21) and albuminuria (51 +/- 15 vs 247 +/- 73 mg/day, respectively, on Day 21). Creatinine clearance was better preserved in MMF-treated DOCA-salt rats compared with untreated DOCA-salt rats (0.74 +/- 0.07 vs 0.49 +/- 0.09 mL/min, respectively; P < 0.05), but was still significantly reduced compared with that in the placebo group (1.15 +/- 0.12 mL/min; P < 0.05). Finally, MMF treatment significantly attenuated the DOCA-salt-induced rise in renal cortical T-lymphocyte and macrophage infiltration (P < 0.05). 4. These data indicate that immune cells play a deleterious role in both the hypertension and renal injury associated with DOCA-salt hypertension.
引用
收藏
页码:1016 / 1022
页数:7
相关论文
共 50 条
  • [21] Altered coronary dilation in deoxycorticosterone acetate-salt hypertension
    Millette, E
    de Champlain, J
    Lamontagne, D
    JOURNAL OF HYPERTENSION, 2000, 18 (12) : 1783 - 1793
  • [22] REGULATION OF VASOPRESSIN RECEPTORS IN DEOXYCORTICOSTERONE ACETATE-SALT HYPERTENSION
    TRINDER, D
    PHILLIPS, PA
    RISVANIS, J
    STEPHENSON, JM
    JOHNSTON, CI
    HYPERTENSION, 1992, 20 (04) : 569 - 574
  • [23] Deoxycorticosterone acetate-salt rats - Hypertension and sympathoexcitation driven by increased NaCl levels
    O'Donaughy, TL
    Brooks, VL
    HYPERTENSION, 2006, 47 (04) : 680 - 685
  • [24] Enhanced Assymetrical Noradrenergic Transmission in the Olfactory Bulb of Deoxycorticosterone Acetate-Salt Hypertensive Rats
    Tamara Abramoff
    María J. Guil
    Vanina P. Morales
    Sandra I. Hope
    Celeste Soria
    Liliana G. Bianciotti
    Marcelo S. Vatta
    Neurochemical Research, 2013, 38 : 2063 - 2071
  • [25] Bioactive Peptides from Ruditapes philippinarum Attenuate Hypertension and Cardiorenal Damage in Deoxycorticosterone Acetate-Salt Hypertensive Rats
    Sun, Zonghui
    Wang, Weixia
    Liu, Jinli
    Zou, Shengcan
    Yin, Dongli
    Lyu, Chenghan
    Yu, Jia
    Wei, Yuxi
    Gramza-Michalowska, Anna
    Kolanowski, Wojciech
    MOLECULES, 2023, 28 (22):
  • [26] EFFECTS OF TETRANDRINE ON LEFT-VENTRICLE HYPERTROPHY IN DEOXYCORTICOSTERONE ACETATE-SALT HYPERTENSIVE RATS
    XU, Y
    RAO, MR
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 278 (01) : 1 - 7
  • [27] Changes in Serum and Renal Vitamin E Levels in Deoxycorticosterone Acetate-Salt Hypertensive Rats
    Seifi, B.
    Kadkhodaee, M.
    Zahmatkesh, M.
    Golab, F.
    Bakhshi, E.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (07) : 2910 - 2911
  • [28] l-Carnitine Attenuates Cardiac Remodelling rather than Vascular Remodelling in Deoxycorticosterone Acetate-Salt Hypertensive Rats
    O'Brien, Daniel
    Chunduri, Prasad
    Iyer, Abishek
    Brown, Lindsay
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 106 (04) : 296 - 301
  • [29] Endothelin enhances and inhibits adrenal catecholamine release in deoxycorticosterone acetate-salt hypertensive rats
    Lange, DL
    Haywood, JR
    Hinojosa-Laborde, C
    HYPERTENSION, 2000, 35 (01) : 385 - 390
  • [30] Enhanced Assymetrical Noradrenergic Transmission in the Olfactory Bulb of Deoxycorticosterone Acetate-Salt Hypertensive Rats
    Abramoff, Tamara
    Guil, Maria J.
    Morales, Vanina P.
    Hope, Sandra I.
    Soria, Celeste
    Bianciotti, Liliana G.
    Vatta, Marcelo S.
    NEUROCHEMICAL RESEARCH, 2013, 38 (10) : 2063 - 2071